News Releases

Advanced Search
  • Jan 3, 2017
    --High-performing HIV viral load test now available alongside broad women's health menu on the fully automated Panther® system--

    Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted PMA approval for the Company's HIV-1 viral load monitoring assay. The Aptima® HIV-1 Quant...

  • Dec 20, 2016

    Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco on January 10, 2017 at 10:30 a.m. Pacific Time. The...

  • Dec 16, 2016

    Hologic, Inc. (Nasdaq: HOLX) announced today that Amy Wendell has been elected to the Company's Board of Directors, effective December 14. Ms. Wendell also was appointed to the Company's Audit and...

  • Dec 14, 2016
    - Transaction Strengthens Hologic's Efforts to Build a Sustainable Growth Company -

    Hologic, Inc. (Nasdaq: HOLX) has entered into a definitive agreement to sell its share of its blood screening business to long-time commercial partner, Grifols (MCE: GRF, MCE: GRF.P and NASDAQ:...

  • Nov 25, 2016
    --New products spotlight Hologic's leading tomosynthesis technology, including the world's first dedicated prone biopsy system with 2D or 3D™ imaging--

    Hologic, Inc. (Nasdaq: HOLX) will highlight its portfolio of innovative, award-winning breast cancer screening and interventional products, including the new Affirm™ prone breast biopsy system,...

Show 5102550100 per page